What is the LSX Nordic Congress?
The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region.
It has been connecting life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic life science and healthcare innovation since 2018.
The mission is to facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with key international healthcare stakeholders.
We are delighted to be hosting the 6th LSX Nordic Congress in Copenhagen, Denmark once again! As the hub of Medicon Valley, the crucible of Scandinavian life sciences, we can’t wait to welcome you all to Copenhagen in October!
Meet our speakers - Lundbeck, AZ, Pfizer, Eli Lilly & more!
President & CEO, Lundbeck
Country President, Nordic, AstraZeneca
European Lead Worldwide Business Development, Pfizer
VP, S&E, Eli Lilly
SVP, Head Listings EMEA, Nasdaq
Senior Director Head of S&E, Novo Nordisk
Global Head of Digital Health Partnerships, Novo Nordisk
Global Head of Digital Markets, Sanofi
Director Digital Health Solutions, Global Corporate Strategy & BD, Lundbeck
Healthcare Partnership Director, Novartis
CEO & Co-founder, Brain+
CEO, Back Bay Life Science Advisors; MD, BioVentures MedTech Funds
Head of Business Development, Philips
VP, Business Transformation & Commercial Excellence EMEA, Zimmer Biomet
M&A Director, Halma
General Manager Nordics, Benelux, Zimmer Biomet
5 reasons to choose LSX Nordic
LSX Nordic focusses almost exclusively on 3 main profiles – Biotech, Medtech and Healthtech CEOs, investors, and large pharma and medtech companies. That means our delegation is extremely focussed, extremely relevant and perfectly matched for partnering and investment.
LSX Nordic offers access to more qualified life science investors than any event in the region. In 2023 will be bringing over 150 of the world’s most active investors to Copenhagen. Fundraising? There’s no better place to be.
LSX Nordic has a highly sophisticated, easy to use and widely adopted 1-2-1 partnering platform. All our attendees are highly qualified and available to contact via a huge range of search criteria. Other events say they do ‘partnering’. We’re the experts at it.
LSX has a 9 year track record of building communities and running events across the world. We have an unrivalled global network of CEOs, investors and pharma and we’ve been bringing the very best of them to the Nordic region for the last 6 years.
As well as partnering, content, showcases and exhibition, LSX Nordic offers a range of smaller group meetings/CEO forums/workshops targeting particular profiles of attendees. This means highly qualified groups of attendees to meet in an interactive and intimate setting and provides you with the opportunity to talk to the people that matter most to you.
450+
participants
150+
international investors & pharma
200+
c-suite company executives
2 days
1:1 partnering
30+
company showcases
Incredibly enjoyable and has provided us with lots of relevant industry connections. Looking forward to the next event!
Hanover 16
A key event for the Nordic life-science scene.
CR Ventures
Great discussion and good networking. I will be back next year!
Novo Holdings
LSX is the Life Science eXecutive partnering community.
We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
contact | privacy policy | good conduct policy | anti-slavery policy | anti-money laundering & financial crime policy | diversity & inclusion policy | terms & conditions
© 2022 all rights reserved by LSX Ltd